The genetic and microbiome clues about who gets long COVID
The genetic and microbiome clues about who gets long COVID
This week's research reveals how our microbiome shapes long COVID experiences and shows that even 'mild' cases in children create lasting challenges. Plus, new insights on why some people can't shake persistent symptoms.
🦠 Your Gut Bacteria May Predict Your Long COVID Experience
Scientists analyzed 349 people with long COVID and discovered something fascinating: the bacteria in your mouth and gut correlate with which symptoms you'll experience.
They identified three distinct symptom patterns: 21% had severe constitutional symptoms (fatigue, brain fog), 17% primarily lost smell/taste, and 62% had minimal lingering symptoms
People with high symptom burden had less diverse gut bacteria, and specific bacterial types linked to nausea and smell/taste problems
Interestingly, they found very little evidence of persistent virus in saliva or stool samples, suggesting bacterial imbalance—not viral persistence—drives many long COVID symptoms
Why this matters: This research points toward potential microbiome-targeted treatments for long COVID. If bacterial dysbiosis contributes to symptom severity, restoring healthy gut bacteria could offer a new therapeutic pathway beyond just managing individual symptoms.
Key Findings
🧒 Even 'Mild' Long COVID Hits Kids Hard for Years
Researchers followed 68 children with persistent long COVID symptoms for 24 months and found that even kids with fewer symptoms (4-5 vs 6.5-9) experienced lasting anxiety, respiratory problems, and school concerns. The study revealed two symptom groups, but both struggled with long-term impacts on daily life. Most participants were older teens (72.1% aged 15-17) and female (82.4%).
🧬 Genetic Clues Explain Why Some Get Long COVID
Scientists discovered that certain immune system genes (HLA alleles) protect against or predispose people to long COVID, ME/CFS, and post-Lyme disease. The protective genes strongly bind to virus proteins, likely helping eliminate infections, while susceptibility genes bind weakly—potentially allowing pathogens to persist. The same genetic patterns appeared across all three conditions, suggesting shared mechanisms.
📊 How You Ask About Long COVID Changes the Numbers
A Michigan study of 3,826 adults revealed dramatic differences in long COVID prevalence depending on survey timing and wording. At 4.4 months post-infection, 17% reported 90+ day symptoms. But 18 months later, 24.5% said they'd 'ever experienced long COVID' while only 10.8% had medical diagnoses. Among those without early symptoms, 17.3% later reported long COVID—and 31.1% with early symptoms later denied having long COVID.
🏥 COVID Survivors Use Healthcare Differently Than Other Respiratory Patients
Italian researchers compared 35,458 COVID-19 survivors to 21,375 other respiratory infection survivors over 12 months. COVID patients had delayed but more frequent specialist visits (75.8% vs 70.3%), more imaging and lung function tests, and higher rates of new diabetes (42% increase), psychiatric (21% increase), and hormonal medications. However, they had fewer overall chronic drug prescriptions and hospitalizations.
🇦🇺 1 in 10 Young Australians Report Long COVID
A survey of 765 Australians aged 15-29 found 11.2% reported ever having long COVID, but only 1 in 10 received medical diagnosis. Those with long COVID were younger, had worse general health, worried more about reinfection, and often had family/friends with similar experiences. Among those with current symptoms, 79.1% reported work difficulties and accomplishing less than desired.
🧓 Age and Breathing Problems Drive Disability in Elderly Long COVID
Brazilian researchers studied 288 elderly long COVID patients using WHO disability assessments and found that being 70+ years old and experiencing shortness of breath were the primary factors increasing disability scores. The study highlights how specific symptoms, rather than just having long COVID generally, determine functional impairment in older adults.
Implications
This week's research reveals long COVID as a complex, multi-system condition where your microbiome, genetics, age, and specific symptoms all influence outcomes. The findings suggest we need personalized approaches—from microbiome restoration to age-specific care—rather than one-size-fits-all treatments.
Studies in this issue
Primary sources used for this newsletter.
- Oral and gut bacteria are linked to different long COVID symptoms regardless of ongoing virus presencemain storyiScience2025-10-27PMID 41142132
- Specialist Care and Follow-up Patterns After Hospitalization for COVID-19 Compared to Other Lung Infectionskey findingInfectious diseases and therapy2025-10-27PMID 41144164
- Disability and related factors in older adults with long COVID in a large Brazilian citykey findingGeriatric nursing (New York, N.Y.)2025-10-22PMID 41124714
- Links Between Immune Genes and Infections in Chronic Fatigue Syndrome and Similar Post-Infection Illnesseskey findingScientific reports2025-10-24PMID 41136524
- Long-term symptoms lasting over 2 years in children and young people after COVID-19key findingBMJ paediatrics open2025-10-22PMID 41125258
- How Different Survey Questions Affect Long COVID Rates and Inequalitykey findingPreventive medicine reports2025-10-27PMID 41142667
- Long COVID in Young People in Victoria, Australia: How Common It Is, Its Effects, and Related Factorskey findingPublic health challenges2025-10-23PMID 41127554
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.